^
BIOMARKER:
HER-2 overexpression
i
Other names: ERBB2, CD340, HER-2, HER2, NEU, NGL, V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2
Entrez ID:
HER-2 overexpression
Breast Cancer
Ogivri (trastuzumab biosimilar)
Sensitive
:
A1
Nanoscale Res Lett - 1wk
HER-2 overexpression
Breast Cancer
ribociclib
Sensitive
:
D
ESMO-BC 2021 - 1wk
HER-2 overexpression
Gastric Cancer
trastuzumab
Sensitive
:
A1
HER-2 overexpression
Hormone Receptor Positive Breast Cancer
Trazimera (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 overexpression
HER2 Positive Breast Cancer
Trazimera (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 overexpression
Gastric Cancer
Trazimera (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 overexpression
Hormone Receptor Positive Breast Cancer
Ontruzant (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 overexpression
HER2 Positive Breast Cancer
Ontruzant (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 overexpression
Gastric Cancer
Ontruzant (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 overexpression
Hormone Receptor Positive Breast Cancer
Ogivri (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 overexpression
HER2 Positive Breast Cancer
Ogivri (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 overexpression
Gastric Cancer
Ogivri (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 overexpression
Hormone Receptor Positive Breast Cancer
Kanjinti (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 overexpression
HER2 Positive Breast Cancer
Kanjinti (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 overexpression
Gastric Cancer
Kanjinti (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 overexpression
Gastric Cancer
Herzuma (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 overexpression
Hormone Receptor Positive Breast Cancer
Herzuma (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 overexpression
HER2 Positive Breast Cancer
Herzuma (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 overexpression
Hormone Receptor Positive Breast Cancer
lapatinib
Sensitive
:
A1
HER-2 overexpression
Hormone Receptor Negative Breast Cancer
trastuzumab + lapatinib
Sensitive
:
A1
HER-2 overexpression
Breast Cancer
lapatinib
Sensitive
:
A1
HER-2 overexpression
Breast Cancer
trastuzumab
Sensitive
:
A1
HER-2 overexpression
Breast Cancer
trastuzumab/hyaluronidase-oysk
Sensitive
:
A1
HER-2 overexpression
Hormone Receptor Positive Breast Cancer
neratinib
Sensitive
:
A1
HER-2 overexpression
Breast Cancer
Ontruzant (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 overexpression
Breast Cancer
Trazimera (trastuzumab biosimilar)
Sensitive
:
A1
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our